Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SpringerOpen
2024-11-01
|
| Reeks: | Future Journal of Pharmaceutical Sciences |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s43094-024-00746-7 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|